{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:56:19Z","timestamp":1783137379451,"version":"3.54.6"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00408-019-00211-w","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T11:47:40Z","timestamp":1551354460000},"page":"189-197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD"],"prefix":"10.1007","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5461-6730","authenticated-orcid":false,"given":"Ren\u00e1ta M.","family":"B\u00f6cskei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9la","family":"Bencz\u00far","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0211-5237","authenticated-orcid":false,"given":"Gy\u00f6rgy","family":"Losonczy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikl\u00f3s","family":"Illy\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Czir\u00e1ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1398-3187","authenticated-orcid":false,"given":"Veronika","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anik\u00f3","family":"Boh\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8983-740X","authenticated-orcid":false,"given":"Andr\u00e1s","family":"Bikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,28]]},"reference":[{"key":"211_CR1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00214-2017","author":"CF Vogelmeier","year":"2017","unstructured":"Vogelmeier CF, Criner GJ, Martinez FJ, et al (2017) Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 Report: GOLD executive summary. Eur Respir J. \n                    https:\/\/doi.org\/10.1183\/13993003.00214-2017","journal-title":"Eur Respir J"},{"key":"211_CR2","doi-asserted-by":"publisher","first-page":"15076","DOI":"10.1038\/nrdp.2015.76","volume":"1","author":"PJ Barnes","year":"2015","unstructured":"Barnes PJ, Burney PG, Silverman EK, Celli BR, Vestbo J, Wedzicha JA, Wouters EF (2015) Chronic obstructive pulmonary disease. Nat Rev Dis Primers 1:15076. \n                    https:\/\/doi.org\/10.1038\/nrdp.2015.76","journal-title":"Nat Rev Dis Primers"},{"issue":"114","key":"211_CR3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1183\/09059180.00005509","volume":"18","author":"A Bourdin","year":"2009","unstructured":"Bourdin A, Burgel PR, Chanez P, Garcia G, Perez T, Roche N (2009) Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities. Eur Respir Rev 18(114):198\u2013212. \n                    https:\/\/doi.org\/10.1183\/09059180.00005509","journal-title":"Eur Respir Rev"},{"issue":"2","key":"211_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S2213-2600(13)70006-7","volume":"1","author":"HO Coxson","year":"2013","unstructured":"Coxson HO, Dirksen A, Edwards LD, Evaluation of CLtIPSEI, et al (2013) The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study. Lancet Respir Med 1 (2):129\u2013136. \n                    https:\/\/doi.org\/10.1016\/S2213-2600(13)70006-7","journal-title":"Lancet Respir Med"},{"issue":"1","key":"211_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1373\/clinchem.2007.097360","volume":"54","author":"RR Packard","year":"2008","unstructured":"Packard RR, Libby P (2008) Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 54(1):24\u201338. \n                    https:\/\/doi.org\/10.1373\/clinchem.2007.097360","journal-title":"Clin Chem"},{"issue":"3","key":"211_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1155\/2009\/504294","volume":"27","author":"M Thuno","year":"2009","unstructured":"Thuno M, Macho B, Eugen-Olsen J (2009) suPAR: the molecular crystal ball. Dis Markers 27(3):157\u2013172. \n                    https:\/\/doi.org\/10.3233\/DMA-2009-0657","journal-title":"Dis Markers"},{"issue":"12","key":"211_CR7","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nrm977","volume":"3","author":"F Blasi","year":"2002","unstructured":"Blasi F, Carmeliet P (2002) uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 3(12):932\u2013943. \n                    https:\/\/doi.org\/10.1038\/nrm977","journal-title":"Nat Rev Mol Cell Biol"},{"key":"211_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4137\/BMI.S8326","volume":"6","author":"A Gustafsson","year":"2011","unstructured":"Gustafsson A, Ajeti V, Ljunggren L (2011) Detection of suPAR in the saliva of healthy young adults: comparison with plasma levels. Biomark Insights 6:119\u2013125. \n                    https:\/\/doi.org\/10.4137\/BMI.S8326","journal-title":"Biomark Insights"},{"key":"211_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1741-7015-10-2","volume":"10","author":"K Donadello","year":"2012","unstructured":"Donadello K, Scolletta S, Covajes C, et al (2012) suPAR as a prognostic biomarker in sepsis. BMC Med 10:2. \n                    https:\/\/doi.org\/10.1186\/1741-7015-10-2","journal-title":"BMC Med"},{"issue":"1","key":"211_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2796.2011.02372.x","volume":"270","author":"J Eugen-Olsen","year":"2011","unstructured":"Eugen-Olsen J (2011) suPAR\u2014a future risk marker in bacteremia. J Intern Med 270(1):29\u201331. \n                    https:\/\/doi.org\/10.1111\/j.1365-2796.2011.02372.x","journal-title":"J Intern Med"},{"issue":"6","key":"211_CR11","doi-asserted-by":"publisher","first-page":"e98923","DOI":"10.1371\/journal.pone.0098923","volume":"9","author":"W Gozdzik","year":"2014","unstructured":"Gozdzik W, Adamik B, Gozdzik A, et al (2014) Unchanged plasma levels of the soluble urokinase plasminogen activator receptor in elective coronary artery bypass graft surgery patients and cardiopulmonary bypass use. PLoS ONE 9(6):e98923. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0098923","journal-title":"PLoS ONE"},{"key":"211_CR12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2147\/COPD.S77654","volume":"10","author":"A Gumus","year":"2015","unstructured":"Gumus A, Altintas N, Cinarka H, et al (2015) Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD. Int J Chron Obstruct Pulmon Dis 10:357\u2013365. \n                    https:\/\/doi.org\/10.2147\/COPD.S77654","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"211_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1590\/s1806-37562017000000151","volume":"44","author":"GH AboEl-Magd","year":"2018","unstructured":"AboEl-Magd GH, Mabrouk MM (2018) Soluble urokinase-type plasminogen activator receptor as a measure of treatment response in acute exacerbation of COPD. J Bras Pneumol 44(1):36\u201341. \n                    https:\/\/doi.org\/10.1590\/S1806-37562017000000151","journal-title":"J Bras Pneumol"},{"issue":"7","key":"211_CR14","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/JIM.0000000000000105","volume":"62","author":"U Can","year":"2014","unstructured":"Can U, Guzelant A, Yerlikaya FH, et al (2014) The role of serum soluble urokinase-type plasminogen activator receptor in stable chronic obstructive pulmonary disease. J Investig Med 62(7):938\u2013943. \n                    https:\/\/doi.org\/10.1097\/JIM.0000000000000105","journal-title":"J Investig Med"},{"key":"211_CR15","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.2147\/COPD.S107409","volume":"11","author":"H Wang","year":"2016","unstructured":"Wang H, Yang T, Li D, et al (2016) Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 11:2369\u20132376. \n                    https:\/\/doi.org\/10.2147\/COPD.S107409","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"2","key":"211_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, et al (2005) Standardisation of spirometry. Eur Respir J 26(2):319\u2013338. \n                    https:\/\/doi.org\/10.1183\/09031936.05.00034805","journal-title":"Eur Respir J"},{"issue":"10","key":"211_CR17","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1097\/HJH.0b013e32833c8a1a","volume":"28","author":"IG Horvath","year":"2010","unstructured":"Horvath IG, Nemeth A, Lenkey Z, et al (2010) Invasive validation of a new oscillometric device (arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity. J Hypertens 28(10):2068\u20132075. \n                    https:\/\/doi.org\/10.1097\/HJH.0b013e32833c8a1a","journal-title":"J Hypertens"},{"issue":"3","key":"211_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/HJH.0b013e3282f314f7","volume":"26","author":"J Baulmann","year":"2008","unstructured":"Baulmann J, Schillings U, Rickert S, et al (2008) A new oscillometric method for assessment of arterial stiffness: comparison with tonometric and piezo-electronic methods. J Hypertens 26(3):523\u2013528. \n                    https:\/\/doi.org\/10.1097\/HJH.0b013e3282f314f7","journal-title":"J Hypertens"},{"issue":"3","key":"211_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/00126097-200206000-00008","volume":"7","author":"Z Nemeth","year":"2002","unstructured":"Nemeth Z, Moczar K, Deak G (2002) Evaluation of the tensioday ambulatory blood pressure monitor according to the protocols of the British Hypertension Society and the Association for the Advancement of Medical Instrumentation. Blood Press Monit 7(3):191\u2013197","journal-title":"Blood Press Monit"},{"issue":"6","key":"211_CR20","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.jcmg.2008.06.010","volume":"1","author":"J Sugawara","year":"2008","unstructured":"Sugawara J, Hayashi K, Yokoi T, et al (2008) Age-associated elongation of the ascending aorta in adults. JACC Cardiovasc Imaging 1(6):739\u2013748. \n                    https:\/\/doi.org\/10.1016\/j.jcmg.2008.06.010","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"211_CR21","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","volume":"41","author":"F Faul","year":"2009","unstructured":"Faul F, Erdfelder E, Buchner A, et al (2009) Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 41(4):1149\u20131160. \n                    https:\/\/doi.org\/10.3758\/brm.41.4.1149","journal-title":"Behav Res Methods"},{"issue":"4","key":"211_CR22","doi-asserted-by":"publisher","first-page":"e60697","DOI":"10.1371\/journal.pone.0060697","volume":"8","author":"I Ivancso","year":"2013","unstructured":"Ivancso I, Toldi G, Bohacs A, et al (2013) Relationship of circulating soluble urokinase plasminogen activator receptor (suPAR) levels to disease control in asthma and asthmatic pregnancy. PLoS ONE 8(4):e60697. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0060697","journal-title":"PLoS ONE"},{"key":"211_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-018-0141-7","author":"A Bikov","year":"2018","unstructured":"Bikov A, Horvath A, Tomisa G, et al.2018) Changes in the burden of comorbidities in patients with COPD and Asthma-COPD Overlap according to the GOLD 2017 Recommendations. Lung. \n                    https:\/\/doi.org\/10.1007\/s00408-018-0141-7","journal-title":"Lung"},{"issue":"4","key":"211_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.trsl.2013.05.001","volume":"162","author":"SP Bhatt","year":"2013","unstructured":"Bhatt SP, Dransfield MT (2013) Chronic obstructive pulmonary disease and cardiovascular disease. Transl Res 162(4):237\u2013251. \n                    https:\/\/doi.org\/10.1016\/j.trsl.2013.05.001","journal-title":"Transl Res"},{"key":"211_CR25","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.2147\/COPD.S141988","volume":"12","author":"I Tuleta","year":"2017","unstructured":"Tuleta I, Farrag T, Busse L, et al (2017) High prevalence of COPD in atherosclerosis patients. Int J Chron Obstruct Pulmon Dis 12:3047\u20133053. \n                    https:\/\/doi.org\/10.2147\/copd.S141988","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"6","key":"211_CR26","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s11739-017-1690-0","volume":"12","author":"P Ambrosino","year":"2017","unstructured":"Ambrosino P, Lupoli R, Iervolino S, et al (2017) Clinical assessment of endothelial function in patients with chronic obstructive pulmonary disease: a systematic review with meta-analysis. Internal Emerg Med 12(6):877\u2013885. \n                    https:\/\/doi.org\/10.1007\/s11739-017-1690-0","journal-title":"Internal Emerg Med"},{"key":"211_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejim.2017.09.030","volume":"45","author":"FF Larsen","year":"2017","unstructured":"Larsen FF, Petersen JA (2017) Novel biomarkers for sepsis: a narrative review. Eur J Internal Med 45:46\u201350. \n                    https:\/\/doi.org\/10.1016\/j.ejim.2017.09.030","journal-title":"Eur J Internal Med"},{"issue":"3","key":"211_CR28","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.thromres.2007.10.017","volume":"122","author":"K Pawlak","year":"2008","unstructured":"Pawlak K, Mysliwiec M, Pawlak D (2008) The urokinase-type plasminogen activator\/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients. Thromb Res 122(3):328\u2013335. \n                    https:\/\/doi.org\/10.1016\/j.thromres.2007.10.017","journal-title":"Thromb Res"},{"issue":"1","key":"211_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2011.10.044","volume":"222","author":"B Fuhrman","year":"2012","unstructured":"Fuhrman B (2012) The urokinase system in the pathogenesis of atherosclerosis. Atherosclerosis 222(1):8\u201314. \n                    https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.10.044","journal-title":"Atherosclerosis"},{"issue":"5","key":"211_CR30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/01.mbc.0000114441.59147.56","volume":"15","author":"MB Steins","year":"2004","unstructured":"Steins MB, Padro T, Schwaenen C, Ruiz S, Mesters RM, Berdel WE, Kienast J (2004) Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions. Blood Coagul Fibrinolysis 15(5):383\u2013391","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"211_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.atherosclerosis.2011.01.049","volume":"216","author":"T Sehestedt","year":"2011","unstructured":"Sehestedt T, Lyngbaek S, Eugen-Olsen J, et al (2011) Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events. Atherosclerosis 216(1):237\u2013243. \n                    https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.01.049","journal-title":"Atherosclerosis"},{"issue":"1","key":"211_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1161\/STROKEAHA.113.003305","volume":"45","author":"M Persson","year":"2014","unstructured":"Persson M, Ostling G, Smith G, et al (2014) Soluble urokinase plasminogen activator receptor: a risk factor for carotid plaque, stroke, and coronary artery disease. Stroke 45(1):18\u201323. \n                    https:\/\/doi.org\/10.1161\/strokeaha.113.003305","journal-title":"Stroke"},{"issue":"1","key":"211_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.atherosclerosis.2014.08.035","volume":"237","author":"MH Sorensen","year":"2014","unstructured":"Sorensen MH, Gerke O, Eugen-Olsen J, et al (2014) Soluble urokinase plasminogen activator receptor is in contrast to high-sensitive C-reactive-protein associated with coronary artery calcifications in healthy middle-aged subjects. Atherosclerosis 237(1):60\u201366. \n                    https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.08.035","journal-title":"Atherosclerosis"},{"issue":"10","key":"211_CR34","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cjca.2015.03.023","volume":"31","author":"GW Hodges","year":"2015","unstructured":"Hodges GW, Bang CN, Wachtell K, et al (2015) suPAR: a new biomarker for cardiovascular disease? Can J Cardiol 31(10):1293\u20131302. \n                    https:\/\/doi.org\/10.1016\/j.cjca.2015.03.023","journal-title":"Can J Cardiol"},{"issue":"3","key":"211_CR35","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.ijcard.2012.03.040","volume":"167","author":"S Lyngbaek","year":"2013","unstructured":"Lyngbaek S, Sehestedt T, Marott JL, et al (2013) CRP and suPAR are differently related to anthropometry and subclinical organ damage. Int J Cardiol 167(3):781\u2013785. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2012.03.040","journal-title":"Int J Cardiol"},{"issue":"1","key":"211_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12931-017-0597-7","volume":"18","author":"RL Zemans","year":"2017","unstructured":"Zemans RL, Jacobson S, Keene J, et al (2017) Multiple biomarkers predict disease severity, progression and mortality in COPD. Respir Res 18(1):117. \n                    https:\/\/doi.org\/10.1186\/s12931-017-0597-7","journal-title":"Respir Res"},{"key":"211_CR37","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1465-9921-12-146","volume":"12","author":"JA Dickens","year":"2011","unstructured":"Dickens JA, Miller BE, Edwards LD, et al (2011) COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respir Res 12:146. \n                    https:\/\/doi.org\/10.1186\/1465-9921-12-146","journal-title":"Respir Res"},{"issue":"9","key":"211_CR38","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.rmed.2013.05.001","volume":"107","author":"J Miller","year":"2013","unstructured":"Miller J, Edwards LD, Agusti A, et al (2013) Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Res 107(9):1376\u20131384. \n                    https:\/\/doi.org\/10.1016\/j.rmed.2013.05.001","journal-title":"Respir Res"},{"issue":"5","key":"211_CR39","doi-asserted-by":"publisher","first-page":"e37483","DOI":"10.1371\/journal.pone.0037483","volume":"7","author":"A Agusti","year":"2012","unstructured":"Agusti A, Edwards LD, Rennard SI, et al (2012) Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS ONE 7(5):e37483. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0037483","journal-title":"PLoS ONE"},{"issue":"1","key":"211_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2006.12.050","volume":"50","author":"MF O\u2019Rourke","year":"2007","unstructured":"O\u2019Rourke MF, Hashimoto J (2007) Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol 50(1):1\u201313. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2006.12.050","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"211_CR41","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/eci.12278","volume":"44","author":"S Botha","year":"2014","unstructured":"Botha S, Fourie CM, Schutte R, et al (2014) Associations of suPAR with lifestyle and cardiometabolic risk factors. Eur J Clin Investig 44(7):619\u2013626. \n                    https:\/\/doi.org\/10.1111\/eci.12278","journal-title":"Eur J Clin Investig"},{"issue":"4","key":"211_CR42","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/eci.12593","volume":"46","author":"J Eugen-Olsen","year":"2016","unstructured":"Eugen-Olsen J, Ladelund S, Sorensen LT (2016) Plasma suPAR is lowered by smoking cessation: a randomized controlled study. Eur J Clin Investig 46(4):305\u2013311. \n                    https:\/\/doi.org\/10.1111\/eci.12593","journal-title":"Eur J Clin Investig"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-019-00211-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-019-00211-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-019-00211-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T19:17:44Z","timestamp":1582831064000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-019-00211-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,28]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["211"],"URL":"https:\/\/doi.org\/10.1007\/s00408-019-00211-w","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,28]]},"assertion":[{"value":"15 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Mikl\u00f3s Illy\u00e9s is a patent owner of the Arteriograph method and has shares in TensioMed Ltd., a company that manufactures the Arteriograph device for measuring arterial stiffness. The other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}